Atlas Trials

SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety

Clinical trial NCT07174947 · RECRUITING

Trial details

NCT number
NCT07174947
Sponsor
First Affiliated Hospital of Wenzhou Medical University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatobiliary MalignancyFluoxetineAnxiety DisordersDepression Disorders
Start date
2025-10-01
Primary completion
2027-10-01
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.